Prehospital Use of Ketamine Versus Midazolam for Sedation in Acute Severe Agitation
Article Sidebar
Main Article Content
Abstract
Objective: Acute severe agitation often requires pharmacologic sedation. While benzodiazepines and antipsychotics are traditional first-line medications for this purpose, recent evidence has shown that prehospital intramuscular (IM) administration of ketamine results in rapid, effective sedation. However, ketamine may be associated with adverse clinical events including a higher intubation rate. The purpose of this study is to compare the efficacy and safety of IM ketamine versus IM midazolam as medications to achieve sedation in the prehospital setting.
Methods: This is a retrospective cohort study of agitated patients with an initial Richmond Agitation-Sedation Scale (RASS) score of at least 3, who were sedated and transported by ambulance to Hartford Hospital. The primary endpoint was incidence of endotracheal intubation occurring during transportation and within one hour after arrival to the emergency department (ED). Secondary endpoints included the percentage of patients who achieved an improved RASS score post drug administration, the use of additional sedating agents and the need for airway and breathing support, and differences in adverse events.
Results: 66 patients in the ketamine group and 68 patients in the midazolam group met inclusion criteria. While more patients in the midazolam group achieved target RASS score of -1, 0, or 1 post drug administration, patients in the ketamine group had a lower mean RASS score post drug administration. There was no difference in endotracheal intubation rates between the two groups (6.1% versus 2.9%, respectively; p = 0.383). However, upon arrival to the ED, more patients in the ketamine group required additional sedating agents as well as airway or respiratory support
Conclusion: Both ketamine and midazolam are relatively safe and efficacious in the prehospital environment. IM ketamine resulted in deeper sedation without increasing intubation rate. However, ED providers receiving patients treated with IM ketamine should prepare for additional sedating agents and airway interventions.
Article Details
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Publishing in IJOP allows authors to keep their copyright while giving IJOP unrestricted copyright permissions. Articles published in IJOP use Creative Common Attribution 4.0 International (CC BY-ND 4.0) licensing. This license requires that re-users give credit to the creator. It allows re-users to copy and distribute the material in any medium or format in unadapted form only, even for commercial purposes. Additional terms apply and can be accessed here.
Publishing in IJOP also allows authors to have contracts for non-exclusive distribution of the Journal's published version of the article, such as posting to an institutional repository or publication in a book, on the condition that the original publication in the original layout format in IJOP is retained and acknowledged.
We permit and encourage authors to post the articles they published in IJOP on their affiliated websites. This helps share the information, encourages citation in other works, and promotes scholarly discourse in the spirit of open access.
References
Burnett, A. M., Peterson, B. K., Stellpflug, S. J., Engebretsen, K. M., Glasrud, K. J., Marks, J., & Frascone, R.J. (2015) The association between ketamine given for prehospital chemical restraint with intubation and hospital admission. Am J Emerg Med; 33(1), 76-79. https://pubmed.ncbi.nlm.nih.gov/25455046/
Cole, J. B., Moore, J.C., Nystrom, P. C., Orozco, B. S., Stellpflug, S. J., Kornas, R. L., Fryza, B. J., Steinberg, L. W., O’Brien-Lambert, A., Bache-Wiig, P., Engebretsen, K. M., & Ho, J. D.. (2016) A prospective study of ketamine versus haloperidol for severe prehospital agitation. Clin Toxicol (Phila), 54(7), 556-62. https://pubmed.ncbi.nlm.nih.gov/27102743/
Cole, J. B., Moore, J. C., Nystrom, P. C., Orozco, B. S., Stellpflug, S. J., Kornas, R. L., Fryza, B. J., Steinberg, L. W., O’Brien-Lambert, A., Bache-Wiig, P., Engebretsen, K. M., & Ho, J. D. (2018) A prospective study of ketamine as primary therapy for prehospital profound agitation. Am J Emerg Med, 36(5), 789-796. https://pubmed.ncbi.nlm.nih.gov/29033344/
Ely, E. W., Truman, B., Shintani, A., Thomason, J. W. W., Wheeler, A. P., Gordon, S., Francis, J., Speroff, T., Gautam, S., Margolin, R., Sessler, C. N., Dittus, R. S., & Bernard, G. R. (2003) Monitoring sedation status over time in ICU patients: Reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA, 289(22), 2983-2991. https://pubmed.ncbi.nlm.nih.gov/12799407/
Ho, J. D., Smith, S. W., Nystrom, P. C., Dawes, D. M., Orozco, B. S., Cole, J. B., & Heegaard, W. G.. (2013) Successful management of excited delirium syndrome with prehospital ketamine: two case examples. Prehosp Emerg Care, 17(2), 274-279. https://pubmed.ncbi.nlm.nih.gov/23231451/
Holland, D., Glober, N., Christopher, S., Zahn, E., Lardaro, T., & O’Donnell, D. (2020) Prehospital sedation with ketamine vs. midazolam: Repeat sedation, intubation, and hospital outcomes. Am J Emerg Med, 38(9), 1748-1753. https://pubmed.ncbi.nlm.nih.gov/32738471/
Keseg, D., Cortez, E., Rund, D., & Caterino, J. (2015) The use of prehospital ketamine for control of agitation in a metropolitan firefighter-based EMS system. Prehosp Emerg Care, 19(1), 110-115. https://pubmed.ncbi.nlm.nih.gov/25153713/
Linder, L. M., Ross, C. A., & Weant, K. A. (2018) Ketamine for the acute management of excited delirium and agitation in the prehospital setting. Pharmacotherapy, 38(1), 139-151. https://pubmed.ncbi.nlm.nih.gov/29136301/
Lipscombe, C., Akhlaghi, H., Groombridge, C., Bernard, S., Smith, K., & Olaussen, A. (2023) Intubation rates following prehospital administration of ketamine for acute agitation: A systematic review and meta-analysis. Prehosp Emerg Care, 27(8), 1016-1030. https://pubmed.ncbi.nlm.nih.gov/35913093/
Mash, D. C. Excited delirium and sudden death: A syndromal disorder at the extreme end of the neuropsychiatric continuum. (2016) Front Physiol, 7:435. https://pubmed.ncbi.nlm.nih.gov/27790150/
Olives, T. D., Nystrom, P. C., Cole, J. B., Dodd, K. W., & Ho, J. D. (2016) Intubation of profoundly agitated patients treated with prehospital ketamine. Prehosp Disaster Med, 31(6), 593-602. https://pubmed.ncbi.nlm.nih.gov/27640730/
Perumal, D. K., Adhimoolam, M., Selvaraj, N., Lazarus, S. P., & Mohammed, M. A. R. (2015) Midazolam premedication for Ketamine-induced emergence phenomenon: A prospective observational study. J Res Pharm Pract, 4(2), 89-93. https://pubmed.ncbi.nlm.nih.gov/25984547/
Takeuchi, A., Ahern, T. L., & Henderson, S. O. (2011) Excited delirium. West J Emerg Med, 12(1), 77–83. https://pubmed.ncbi.nlm.nih.gov/21691475/
Wells, M., Henry, B., & Goldstein, L. (2023) Weight estimation for drug dose calculations in the prehospital setting: a systematic review. Prehosp Disaster Med, 38(4), 471-484. https://pubmed.ncbi.nlm.nih.gov/37439214/
Vien, A., & Chhabra, N. (2017) Ketamine-induced muscle rigidity during procedural sedation mitigated by intravenous midazolam. Am J Emerg Med, 35(1). https://pubmed.ncbi.nlm.nih.gov/27595173/